Copyright Seeking Alpha
Kimberly-Clark to acquire Kenvue in $48.7 billion deal Nov. 03, 2025 7:04 AM ETKimberly-Clark Corporation (KMB) Stock, KVUE StockBy : Preeti Singh, SA News Editor Comments (11) Kimberly-Clark (KMB) shares plunged over 15% premarket on Monday after the consumer goods firm entered a deal to acquire all outstanding shares of Tylenol-maker Kenvue (KVUE) in a cash and stock transaction. The transaction is expected to close in the Quick Insights The deal offers immediate value to Kenvue shareholders via $6.8 billion in upfront cash and a share premium, though Kimberly-Clark shares have dropped over 15% premarket, reflecting investor concern or uncertainty. The combined company is projected to generate about $32 billion in annual net revenues and ~$7 billion in adjusted EBITDA, with $1.9 billion in cost synergies and $500 million in revenue synergies expected after integration. The companies estimate $2.5 billion in cash costs over two years to achieve $1.9 billion cost savings (in three years) and $500 million revenue gain (in four years), partly offset by $300 million in reinvestment. Recommended For You
